New England Journal of Medicine

A few October resolutions tips  Thanks to the Cornell's Food and Brand Lab for sharing these study findings and the image
The primary objective of the trial was to see whether premature babies were more likely to die or suffer retinal damage, which
It is obvious to anyone familiar with either journalistic ethics in general or Lyme disease specifically that Salzberg's
REFERENCES: Read more in Public Citizen's March Health Letter By backsliding on long-standing ethical commitments and violating
We need to focus on preventing new addictions and using the harm-reduction approach to treat current addicts.
I write this as a physician who can see through the façade and racket of what corporate medicine has created. My history of abuse gives me the sensitivity to feel it when it is present. The corporate system of health care is abusive.
The movement toward "good" death - legalized medical aid in dying - has been growing for decades in the U.S., but has been gaining momentum and attention in recent months.
We need to return to the patient-centered care that Dr. Arnold Relman advocated for throughout his professional life rather than continue with the present disease-centered system if we truly want to reduce the burden of disease.
Critics don't want to admit that they've run out of criticisms of Obamacare. The website is working, enrollments are surging, and millions of Americans are getting affordable, high-quality health insurance.
Public investment in research has not been enough to keep America in its lofty global leadership perch. According to the
"The real value of antibiotics is saving people from dying. Everything else is trivial," Hollis concludes. What's more, this
All military physicians are licensed by somebody and should be investigated if there were any suspicions of participation in torture, however defined.
An amazing X-ray released by the New England Journal of Medicine on Wednesday shows a 0.79 inch metal screw in the 57-year
When the government re-opened, it failed to address the arbitrary, across-the-board sequester that is systematically weakening the federal research enterprise. This may have superficial appeal on short-term balance sheets, but it's handicapping long-term prospects.
For employers and policymakers frustrated by America's embarrassingly poor performance in nearly every known indicator of health care quality, this study offers two breakthrough glimmers of hope.
We should reconsider our thought process on what underlies Alzheimer's, especially as it relates to the role of beta-amyloid. Remember, the enemy of my enemy is my friend.
My hunch is that obstetricians on the front lines -- the ones who counsel pregnant women every day about their testing options -- will realize that the new tests are just plain better. Patients of all ages -- who can inform themselves more easily than ever before -- will demand them too.
Do you plan to live to 85? If you do, there's a 1 in 3 chance you'll have Alzheimer's. Here's the bad news: There is no cure.